Publications by authors named "Libo Tang"

Claim this Profile
D
Dissecting antibody-mediated NK cell effects reveals a cytotoxic CX3CR1⁺KLRC2⁻CD16hisubset linked to HBV outcomes.
Libo Tang, Yuhao Wang, Zihan Jin, Yurong Gu, Zhaofeng Zeng

Clin Mol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-21 attenuates liver inflammation by enhancing myeloid-derived suppressor cells immunosuppressive function in chronic HBV infection.
Xiaoyi Li, Zihan Jin, Meihan Pan, Zheyu Dong, Junlin Chen, Libo Tang

J Transl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LUBAC subunit HOIL-1 promotes the progression of HBV-associated hepatocellular carcinoma independently of linear ubiquitination.
Zheyu Dong, Qiuyue Ye, Yuxin Zhou, Yuqing Shao, Junling Chen, Libo Tang

Exp Mol Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell Profiling of Peripheral and Intrahepatic B Cells Reveals Altered Responses and a CCR7⁺ Subset Linked to Antiviral Potential in Chronic HBV Infection.
Shihong Zhong, Zhaofeng Zeng, Zihan Jin, Lingtao Zhang, Guofu Ye, Libo Tang

J Med Virol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer.
Li-Bo Tang, Ying-Long Peng, Ji Chen, Jia-Ting Li, Mei-Mei Zheng

Nat Rev Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases.
Mei-Mei Zheng, Qing Zhou, Hua-Jun Chen, Ben-Yuan Jiang, Li-Bo Tang

Nat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial response to lorlatinib in thoracic inflammatory myofibroblastic tumor harboring complex and rare ALK fusions: a case report.
Li-Bo Tang, Ying-Long Peng, Xiao-Rong Yang, Jia-Ting Li, Chang Lu

Transl Lung Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating HBsAg-specific B cells are partially rescued in chronically HBV-infected patients with functional cure.
Shuqin Gu, Libo Tang, Ling Guo, Chunxiu Zhong, Xin Fu

Emerg Microbes Infect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HBc mirrors the activation of HBV-specific CD8 T cell immune response and exhibits a direct effect on HBV control.
Guofu Ye, Chengcong Chen, Yongjun Zhou, Libo Tang, Jianzhong Cai

Antiviral Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC.
Peng Chen, Zheyu Dong, Wei Zhu, Junling Chen, Yuxin Zhou, Libo Tang

Hepatology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Targeting with Apatinib-loaded Nanoparticles and Sonodynamic Combined Therapy.
Xiao Han, Caifu Zhou, Xiaoling Luo, Hongbing Pang, Chuangye Han, Libo Tang

Curr Mol Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer.
Wei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, Zhi-Hong Chen, Yi-Chen Zhang, Li-Bo Tang

J Transl Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of COVID-19 and Lung Cancer: Short-Term and Long-Term Interactions.
Ying-Long Peng, Zi-Yan Wang, Ri-Wei Zhong, Shi-Qi Mei, Jia-Qi Liu, Li-Bo Tang

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA (ctDNA)-based minimal residual disease in non-small cell lung cancer.
Libo Tang, Ruiyang Li, Huahai Wen, Qing Zhou, Chongrui Xu

Chin Med J Pulm Crit Care Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-21 collaborates with anti-TIGIT to restore NK cell function in chronic HBV infection.
Libo Tang, Quanrun Li, Liang Chen, Xiaowei Li, Shuqin Gu

J Med Virol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential response of HBV envelope-specific CD4 + T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapy.
Yongyin Li, Chunhua Wen, Shuqin Gu, Weibin Wang, Ling Guo, Libo Tang

Hepatology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peyer's patch-involved gut microbiota facilitates anti-HBV immunity in mice.
Yifan Li, Shihong Zhong, Zihan Jin, Guofu Ye, Tianling Zhang, Libo Tang

Virus Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal associations between chronic hepatitis B and COVID-19 in East Asian populations.
Zhenguo Liu, Linnan Song, Junling Chen, Yongjun Zhou, Yuhao Wang, Libo Tang

Virol J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBV Core-specific CD4 T cells correlate with sustained viral control upon off-treatment in HBeAg-positive chronic hepatitis B patients.
Chunhua Wen, Yang Zhou, Yongjun Zhou, Yiyue Wang, Zheyu Dong, Libo Tang

Antiviral Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing immunity to SARS-CoV-2 associates with strong T cell responses induced by inactivated COVID-19 vaccines.
Xuan Yi, Yuhao Wang, Quanrun Li, Xiaoyi Li, Panli Zhang, Libo Tang

J Med Virol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA4CD4CXCR5FOXP3 T cells associate with unfavorable outcome in patients with chronic HBV infection.
Chunhua Wen, Zheyu Dong, Yiyue Wang, Guofu Ye, Yanchen Ma, Libo Tang

BMC Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon α facilitates anti-HBV cellular immune response in a B cell-dependent manner.
Shihong Zhong, Qiong Li, Chunhua Wen, Yifan Li, Yang Zhou, Libo Tang

Antiviral Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal mapping of hepatitis B vaccine-induced B-cell linear epitopes in healthy individuals.
Shihong Zhong, Zhipeng Liu, Yang Zhou, Tianling Zhang, Xin Fu, Libo Tang

J Med Virol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired CD8 T cells in term pregnancy decidua with chronic hepatitis B virus infection.
Yanchen Ma, Xiaoyi Liu, Haonan Lou, Liang Chen, Weiying He, Libo Tang

Am J Reprod Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long noncoding RNA LINC00930 promotes PFKFB3-mediated tumor glycolysis and cell proliferation in nasopharyngeal carcinoma.
Baoyu He, Hongli Pan, Fengque Zheng, Saiqiong Chen, Qingli Bie, Libo Tang

J Exp Clin Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis